Cover Image

Ethics of trending in pharmaceutical & therapeutic-related biotechnology

There exist a large disparity between the developed and developing countries, in terms of accessing affordable medication. Pharmaceuticals are generally costly; due to the high capital costs involved, as well as the cost of abiding by regulations, standardization, safety & purity concerns. Howev...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Gameil, Abeir Hussein, Kabbashi, Nassereldeen Ahmed
Format: Conference or Workshop Item
Language:English
Published: 2013
Subjects:
L Education (General)
Online Access:http://irep.iium.edu.my/35622/1/ICEPEE4048.pdf
http://irep.iium.edu.my/35622/
http://www.iium.edu.my/icepee/2013
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.iium.irep.35622
record_format dspace
spelling my.iium.irep.356222014-02-18T03:35:34Z http://irep.iium.edu.my/35622/ Ethics of trending in pharmaceutical & therapeutic-related biotechnology M. Gameil, Abeir Hussein Kabbashi, Nassereldeen Ahmed L Education (General) There exist a large disparity between the developed and developing countries, in terms of accessing affordable medication. Pharmaceuticals are generally costly; due to the high capital costs involved, as well as the cost of abiding by regulations, standardization, safety & purity concerns. However, it can also be observed that the biotechnology industry has shifted focus towards health areas that would bring the most profits. This may seem alright when the health areas are those related to diseases that rank high in mortality. However, what of health areas that do not put the patients in mortal danger, for example, skin diseases, weight-loss, and hair loss? Compared to cancer, diabetes, asthma, and kidney failure, obviously these issues, whilst being damaging to self-esteem & social life, are not as severe. On the other hand, there are children who have rare and debilitating diseases that limit their life expectancy to childhood. If the industries as well as the research funders continue to trend this way, what would remain of funds for these diseases? This paper seeks to enlighten on the underlying ethical dangers of this trend. The paper also re-emphasizes the value of technology transfer in aiding research related to these diseases for purposes of early diagnosis as well as therapeutics, through biotechnology. 2013-07-02 Conference or Workshop Item REM application/pdf en http://irep.iium.edu.my/35622/1/ICEPEE4048.pdf M. Gameil, Abeir Hussein and Kabbashi, Nassereldeen Ahmed (2013) Ethics of trending in pharmaceutical & therapeutic-related biotechnology. In: 3rd International Conference on Engineering Professional Ethics and Education 2013 (ICEPEE’13), 2-4 July 2013, Kuala Lumpur. http://www.iium.edu.my/icepee/2013
institution Universiti Islam Antarabangsa Malaysia
building IIUM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
url_provider http://irep.iium.edu.my/
language English
topic L Education (General)
spellingShingle L Education (General)
M. Gameil, Abeir Hussein
Kabbashi, Nassereldeen Ahmed
Ethics of trending in pharmaceutical & therapeutic-related biotechnology
description There exist a large disparity between the developed and developing countries, in terms of accessing affordable medication. Pharmaceuticals are generally costly; due to the high capital costs involved, as well as the cost of abiding by regulations, standardization, safety & purity concerns. However, it can also be observed that the biotechnology industry has shifted focus towards health areas that would bring the most profits. This may seem alright when the health areas are those related to diseases that rank high in mortality. However, what of health areas that do not put the patients in mortal danger, for example, skin diseases, weight-loss, and hair loss? Compared to cancer, diabetes, asthma, and kidney failure, obviously these issues, whilst being damaging to self-esteem & social life, are not as severe. On the other hand, there are children who have rare and debilitating diseases that limit their life expectancy to childhood. If the industries as well as the research funders continue to trend this way, what would remain of funds for these diseases? This paper seeks to enlighten on the underlying ethical dangers of this trend. The paper also re-emphasizes the value of technology transfer in aiding research related to these diseases for purposes of early diagnosis as well as therapeutics, through biotechnology.
format Conference or Workshop Item
author M. Gameil, Abeir Hussein
Kabbashi, Nassereldeen Ahmed
author_facet M. Gameil, Abeir Hussein
Kabbashi, Nassereldeen Ahmed
author_sort M. Gameil, Abeir Hussein
title Ethics of trending in pharmaceutical & therapeutic-related biotechnology
title_short Ethics of trending in pharmaceutical & therapeutic-related biotechnology
title_full Ethics of trending in pharmaceutical & therapeutic-related biotechnology
title_fullStr Ethics of trending in pharmaceutical & therapeutic-related biotechnology
title_full_unstemmed Ethics of trending in pharmaceutical & therapeutic-related biotechnology
title_sort ethics of trending in pharmaceutical & therapeutic-related biotechnology
publishDate 2013
url http://irep.iium.edu.my/35622/1/ICEPEE4048.pdf
http://irep.iium.edu.my/35622/
http://www.iium.edu.my/icepee/2013
_version_ 1643610825057894400
score 13.211869

Similar Items